Weekly pill aims to turn back the clock on aging
NCT ID NCT05949658
First seen Feb 10, 2026 · Last updated Jun 18, 2026 · Updated 20 times
Summary
This study tests two drugs, sirolimus and everolimus, taken once a week to see if they can safely slow the aging process in healthy adults aged 55 to 89. Participants take one of three dose levels for 6 weeks, and researchers monitor side effects and drug levels in the blood. The goal is to find a dose that works without causing serious problems.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AGING are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Wisconsin
RECRUITINGMadison, Wisconsin, 53705, United States
Contact
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.